Primary Medication Reconciliation Service Provided by Clinical Pharmacist for Chronic Kidney Disease in Our Hospital
WANG Hui-xia1,2, ZHU Xu-ting1,3, XIE Cheng1, QIAN Yu-lan1, SUN Shu-sen4, HANG Yong-fu1*
1. Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006, China; 2. Department of Pharmacy, Danyang People��s Hospital of Jiangsu Province, Danyang 212300, China; 3. Department of Pharmacy, The Third People��s Hospital of Wuxi, Wuxi 214000, China; 4. College of Pharmacy and Health Sciences, Western New England University, Springeld, Massachusetts 01119, USA
Abstract��OBJECTIVE To evaluate the efficacy of medication reconciliation (MR) service provided by clinical pharmacist for chronic kidney disease(CKD).METHODS Patients with CKD administered in department of nephrology between Dec, 2017 and Mar. Total of 2018 who met the inclusion criteria were given MR service, and the newest Pharmaceutical Care Network Europe (PCNE) V8.02 classification scheme was constructed for drug related problems (DRP) to analysis and summary.RESULTS MR was conducted 48 times (accounted for 80%) on 60 patients during the study period. Total of 59 medication DRP were identified. The most common DRP was treatment effectiveness (accounted for 84.75%), there were 54 causes (accounted for 76.06%) were prescribing in 71 causes, all the causes were classified as likely to cause level 1 harm (accounted for 84.75%), clinical pharmacists made 145 interventions, 102 (70.34%) of these were completely accepted and implement.CONCLUSION DRPs are common in CKD patients, clinical pharmacists should provide MR for CKD patients, and conducted as routine work.
Joint Commission on Accreditation of Healthcare Organizations, USA. Using medication reconciliation to prevent errors. Sentinel Event Alert, 2006,32(35):1-4.
[2]
ZIMMERMAN K M, SALGADO T M, DIXON D L. Medication reconciliation vs medication review. JAMA, 2017,318(10):965-966.
[3]
YAO H J, LI P, LIU X Z, et al. Pharmaceutical care practice for admission medication reconciliation in the internal medicine inpatient by clinical pharmacists. J China Pharm (�й�ҩ��), 2017, 28(32):4580-4584.
[4]
WU L L, ZHANG X R, HOU J Q, et al. Practice of medication reconciliation among chronic renal insufficiency patients by clinical pharmacists . J China Pharm (�й�ҩ��), 2017, 28(14):2002-2005.
[5]
CHEN M, ZHANG G W, DU M, et al. Medication reconciliation practice for cancer patients by clinical pharmacists. Eval Anal Drug-Use Hosp China(�й�ҽԺ��ҩ���������), 2017, 17(7):989-990, 993.
[6]
HO C P, JF L T. The reliability and validity of the Chinese version of the eight-item morisky medication adherence scale. Value Health, 2014,17(7):A730.
[7]
Foundation, PCNE. PCNE Classification for drug related problemsV8.02. . . http://www.pcne.org/upload/files/230_PCNE_classification_V8-02.pdf.
[8]
BAYLIFF C D,EINARSON T R. Physician assessment of pharmacists�� interventions--a method of estimating cost avoidance and determining quality assurance. Can J Hosp Pharm, 1990,43(4):167-171, 195.
[9]
MUELLER S K, SPONSLER K C, KRIPALANI S, et al. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med, 2012,172(14):1057-1069.
[10]
LIU Y, CUI X L, LIU L H. Brief analysis of medication reconciliation between domestic and foreign. Chin Pharm J(�й�ҩѧ��־), 2015, 50(24):2099-2112.
[11]
ZHANG L,WANG F,WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 379(9818):815-822.
[12]
CHEN C Y, SHENG X Y, LIANG Y, et al. Pharmacists�� participation in the management of chronic kidney disease: a systematic review. Chin Pharm J(�й�ҩѧ��־), 2015, 50(1):80-84.
2018, Vol. 53 
